The neutralization effect of montelukast on SARS-CoV-2 is shown by multiscale in silico simulations and combined in vitro studies
Serdar Durdağı, Timuçin Avşar, Müge Didem Orhan, Müge Serhatlı, Bertan Koray Balcıoğlu, Hasan Ümit Öztürk, Alişan Kayabölen, Yüksel Çetin, Şeyma Aydınlık, Tugba Bagcı-Önder, Şaban Teki̇n, Hasan DeMi̇rci̇, Mustafa Güzel, Atilla Akdemir, Seyma Calis, Lalehan Oktay, İlayda Tolu, Yasar Enes Butun, Ece Erdemoğlu, Alpsu Olkan, Nurettin Tokay, Şeyma Işık, Aysenur Ozcan, Elif Acar, Sehriban Buyukkilic, Yesim Yumak
Topics & Concepts
In silicoMontelukastNeutralizationIn vitroSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)Virology2019-20 coronavirus outbreakComputational biologyBiologyChemistryMedicineImmunologyGeneticsVirusPathologyDiseaseGeneInfectious disease (medical specialty)AsthmaOutbreakSARS-CoV-2 and COVID-19 ResearchComputational Drug Discovery MethodsCOVID-19 Clinical Research Studies